We have determined the three-dimensional solution structure of the complex of Lactobacillus casei dihydrofolate reductase and the anticancer drug trimetrexate. Two thousand seventy distance, 345 dihedral angle, and 144 hydrogen bond restraints were obtained from analysis of multidimensional NMR spectra recorded for complexes containing 15 N-labeled protein. Simulated annealing calculations produced a family of 22 structures fully consistent with the constraints. Several intermolecular protein-ligand NOEs were obtained by using a novel approach monitoring temperature effects of NOE signals resulting from dynamic processes in the bound ligand. At low temperature~5 8C! the trimethoxy ring of bound trimetrexate is flipping sufficiently slowly to give narrow signals in slow exchange, which give good NOE cross peaks. At higher temperature these broaden and their NOE cross peaks disappear thus allowing the signals in the lower-temperature spectrum to be identified as NOEs involving ligand protons. The binding site for trimetrexate is well defined and this was compared with the binding sites in related complexes formed with methotrexate and trimethoprim. No major conformational differences were detected between the different complexes. The 2,4-diaminopyrimidine-containing moieties in the three drugs bind essentially in the same binding pocket and the remaining parts of their molecules adapt their conformations such that they can make effective van der Waals interactions with essentially the same set of hydrophobic amino acids, the side-chain orientations and local conformations of which are not greatly changed in the different complexes~similar x 1 and x 2 values!.
and ionization states in several complexes of dihydrofolate reductase with substrates and inhibitors~Birdsall et al., 1981 substrates and inhibitors~Birdsall et al., , 1982 substrates and inhibitors~Birdsall et al., , 1984 substrates and inhibitors~Birdsall et al., , 1989a substrates and inhibitors~Birdsall et al., , 1989b substrates and inhibitors~Birdsall et al., , 1990 substrates and inhibitors~Birdsall et al., , 1997 Cocco et al., 1981; Gronenborn et al., 1981; Antonjuk et al., 1984; Clore et al., 1984; Bevan et al., 1985; Hammond et al., 1986; Searle et al., 1988; Carr et al., 1991; Cheung et al., 1993; Falzone et al., 1994; Epstein et al., 1995; Polshakov et al., 1995a; Gargaro et al., 1996; Gerothanassis et al., 1996; Nieto et al., 1997!. In the search for improved inhibitors of dihydrofolate reductase, numerous antifolate analogues have been synthesized and investigated~Roth & Cheng, 1982; Baccanari & Kuyper, 1993 !. One promising antifolate analogue is trimetrexate~2,4-diamino-5-methyl-6-@~3,4,5-trimethoxyanilino!methyl#quinazoline!~Fig. 1A!~Bertino et al., 1979!. Trimetrexate was first prepared by Elslager and co-workers Elslager et al., 1983 ! and was investigated initially as a potential antimalarial agent. Subsequently, it was found to have antineoplastic activity in relation to breast, head, and neck cancers~Robert, 1988! and later it was used as an antibacterial in the treatment of Pneumocystis carinii pneumonia~PCP! in AIDS patients~Lin & Bertino, 1987!. In 1993 trimetrexate~neutrexin! was approved by the U.S. Food and Drug Administration for the treatment of moderateto-severe PCP in people with compromised immune systems.
The structure of trimetrexate~Fig. 1A! combines some of the features of trimethoprim~Fig. 1B! and methotrexate~Fig. 1C!. Because trimetrexate lacks the terminal glutamic acid moiety of methotrexate, it is more lipophilic and does not need active transport for penetration into the cell~Lin & Bertino, 1991!. This significantly increases its efficacy against cells resistant to methotrexate.
Inhibition studies with the human enzyme show that although trimetrexate is about an order of magnitude less potent than methotrexate, it is still an extremely tightly-binding inhibitor~Jackson et al., 1984!. Recent studies on the antipneumocystis activity of trimetrexate have stimulated the synthesis and biological testing of several new nonclassical antifolates~Gangjee et al., 1996!. Gangjee and coworkers have used computer assisted molecular modeling of complexes of dihydrofolate reductase to help in developing novel antifolates~Gangjee et al., 1995!. Such rational drug design studies could be improved if more structural information were available for complexes of dihydrofolate reductases and trimetrexate.
In the present work, we report the high resolution solution structure of the binary complex of Lactobacillus casei dihydrofolate reductase with trimetrexate. Detailed information about the conformation of the bound drug and the structure of its binding site has been obtained. This information allows us to compare the binding site with those of methotrexate~Gargaro et al., 1998! and trimethoprim~Martorell et al., 1994 ! and to examine any differences in their modes of binding. The dynamics of the protein and the bound drug and the specific interactions between the enzyme with the drug have also been characterized.
Results

Signal assignments for the DHFR{trimetrexate complex
These assignments for the complex were made by analyzing 2D 1 H NMR spectra of the DHFR{trimetrexate complex obtained from COSY, TOCSY, NOESY, and ROESY experiments and 3D 15 N-1 H NMR spectra from TOCSY-HMQC, NOESY-HMQC, ROESY-HMQC, and HNHB experiments carried out on uniformly 15 N-labeled DHFR samples using procedures similar to those described earlier for the DHFR{methotrexate complex~Carr et al., 1991; Gargaro et al., 1998!. The 15 N-1 H HSQC spectrum of the DHFR{trimetrexate complex with all the resonances labeled is shown in Figure 2 and a table containing the 1 H and 15 N signal assignments is provided in Electronic supplementary material.
In earlier studies on the DHFR{methotrexate complex, almost complete assignments of the proton NMR signals were obtained by analyzing the 3D and 4D spectra from experiments carried out on uniformly 15 N and 13 C0 15 N labeled enzyme~Soteriou et al., 1993; Gargaro et al., 1998 !. These assignments for the DHFR{methotrexate complex assisted in the assignment of signals from some of the long-chain amino acids in the spectra of the DHFR{trimetrexate complex, because many signals have similar chemical shifts in the two complexes and show similar patterns of NOEs.
Coupling constant and distance-related NMR data were used to derive the stereospecific assignments of b-methylene protons and of valine g-methyl groups using the program AngleSearch as described in Materials and methods~Polshakov et al., 1995b!. Signals from all the side-chain amide protons of asparagine and glutamine residues could easily be assigned in 2D 15 N-1 H TOCSY-HMQC and the 3D 15 N-1 H TOCSY-HMQC and NOESY-HMQC spectra by identifying characteristic NOE patterns involving the NH 2 amide side-chain protons. The side-chain amide protons Hg22 in asparagine and Hd22 in glutamine were determined as those closer to Hb protons~or Hg protons in glutamine! than are Hg21 or Hd21, respectively, and the stereospecific assignments of these protons could thus be obtained directly from the intensity information in ROESY spectra. In the 3D ROESY-HMQC spectra, correlations between amide proton of asparagine and glutamine residues sometimes had different polarities for different residues as a result of contributions to the intensities from exchange and NOE effects having opposite signs. Thus, for Q7, Q33, N59, Q92, and N148, strong negative cross peaks between Hd21 and Hd22~Hg21 and Hg22 for asparagine! were observed indicating that the NOE contribution is dominant for these protons. In contrast, for other residues, cross peaks with positive polarity were observed and these indicated the predominant occurrence of magnetization transfer as a result of exchange from rotation about the amide bond. For the former residues, the absence of a large exchange contribution indicates hindered rotation about their amide bonds and these residues were subsequently found to be buried inside the protein or involved in hydrogen bond formation. In contrast, the side chains of the remaining asparagine and glutamine residues were found on the surface of the protein.
At 288 K, the HE signals for all eight arginine residues in L. casei DHFR could be observed in the 3D 15 N-NOESY-HMQC and TOCSY-HMQC spectra. These signals have cross peaks to arginine side-chain Hd protons in the TOCSY spectra. Such signals were assigned by identifying similar patterns of cross peaks in the 3D TOCSY-HMQC spectrum from the HE proton compared with cross peaks in the 3D 15 N-1 H NOESY-HMQC spectrum connected to the backbone amide NH signals of arginine residues.
Assignment of ligand signals
The signals in the 1 H spectrum of uncomplexed trimetrexate in H 2 O solution were assigned on the basis of their characteristic chemical shifts, intensities, multiplicities, and intramolecular NOEs see Table 2 !. The 1 H chemical shifts were measured as a function of pH~over the range 4.8 to 9.3!, confirming that the site of protonation on the quinazoline ring of trimetrexate is at N1 with a pK a of 7.93 6 0.03. In the 1 H spectrum of the complex recorded in H 2 O at 288 K, a signal detected at 15.46 ppm could be assigned to the HN1 proton of the quinazoline ring of protonated bound trimetrexate on the basis of the build-up of large intramolecular NOEs to the HN21 and H8 and smaller NOEs to the HN22 and H7 protons. Similar low field signals have been observed for the HN1 protons of bound methotrexate~16. 85 ppm!~Gargaro et al., 1998! and trimethoprim~14.9 ppm!~Martorell et al., 1994!. Correlations between H7 and H8 and between HN21 and HN22 were detected in the COSY spectrum, thus confirming these assignments. Other signals in bound trimetrexate were assigned on the basis of their intramolecular NOEs, and COSY and TOCSY connections.
The assignments of the CH 3 -39,59 and H-29,69 protons from the trimethoxybenzyl ring of bound trimetrexate were made by noting variations in linewidth resulting from changes in rates of ring flipping with temperature in their 2D and 1D spectra measured as a function of temperature. Part of the 1 H ROESY spectrum recorded at 288 K showing the exchange cross peaks~in boxes! connecting the exchanging H29 and H69, and CH 3 -39 and CH 3 -59 protons is presented in Figure 3A . The exchange is caused by ring flipping and the signals are readily detectable in the ROESY spectrum because they have opposite signs to other cross peaks that arise from dipolar relaxation interactions. In the 1 H NOESY spectrum recorded at low temperature~278 K! shown in Figure 3B , the exchange cross peaks between the H29 and H69 protons are still detected although with lower intensity. Examination of Figure 3B indicates that it is relatively easy to detect the additional NOE cross peaks that appear when the lines become narrower on lowering the temperature where the slower ring-flipping results in the signals from the ring protons being in slow exchange. This proved to be a very effective method for identifying both inter-and intramolecular NOEs involving the exchanging protons~see below!.
The AngleSearch program was used to determine the stereospecific assignments of methylene protons at position 9 in trimetrexate. Intramolecular ROESY intensities were used in the AngleSearch calculations. Because there is no chiral center in the trimetrexate molecule, the stereospecific assignments of the CH 2 -9 protons in bound trimetrexate have been made in a manner similar to that described for glycine residues in the methotrexate{DHFR complex Polshakov et al., 1995b !. For the two alternative assignments of the methylene CH 2 -9 protons, ranges of t 1 and t 2 torsion angles were obtained from AngleSearch calculations and the correct assignment selected by comparison of these angles with the torsion angles found in the families of NMR structures calculated without using restraints on these torsion angles. This led to the determination of both the stereospecific assignments of the methylene CH 2 -9 protons and the allowed ranges of torsion angles t 1~C 5-C6-C9-N10! and t 2~C 6-C9-N10-C19! in bound trimetrexate. These constraints were used in the final stage of structure calculations 1708 6 308 for t 1 and 908 6 308 for t 2 !.
Assignment of protein-ligand NOEs
Once the assignment of the protein and ligand signals had been completed, most protein-ligand NOEs~Fig. 4! could be assigned A B from 2D NOESY spectra recorded with 50 and 100 ms mixing time at 308, 288 and 278 K. In most cases ligand NOE partners could be assigned unambiguously because of their unique chemical shifts or characteristic line shapes. Signals from the 29,69-ring protons and the 39,59-methoxy protons of the trimethoxyphenyl ring could be uniquely identified because of their changes in line shape with temperature: decrease of temperature caused these signals to become sharper due to slower ring flipping whereas most of the protein signals became broader. This ability to manipulate the detection of NOEs by raising or lowering the temperature greatly facilitated the detection of the protein-ligand NOEs. Furthermore, the availability of NOEs involving resolved protons from opposite sides of the ring increases the total number of detected NOEs. The method has general applicability in cases where there is an intramolecular rate process that can influence the line width of the ligand signals differently as the temperature is changed. In some cases, protein partners in protein-ligand NOEs were also assigned by identifying their characteristic set of NOEs~for example, the trimetrexate H8 proton has NOEs to several protons of L27-Ha, Hg, Hd1, and Hd2!. For assignment of the remaining NOEs, the ambiguities were resolved in an iterative manner during the refinement stage of the structure calculation. A summary of the extensive number of intermolecular NOEs between trimetrexate and protein protons is given in Figure 4 .
Structure of the DHFR{trimetrexate complex
The structures shown in Figure 5 are from the final 22 calculated structures superimposed on the backbone of the representative structure S rep . Figure 5A shows a stereoview of the protein backbone and ligand heavy atoms for all 22 structures. Figure 5B shows some of the important protein side chains and the ligand in its binding site. The structures of bound trimetrexate are shown in Figure 5C . All the structures shown in Figures 5A-C are presented in the same orientation. Some indication of the precision of the structures can be realized by noting how well the different calculated structures are superimposed~pairwise RMSD is 0.5 Å for backbone atoms and 1.0 Å for all heavy atoms!. The absence of dihedral angle and NOE violations and the small energies for the experimental constraints~see Table 1 ! provide further evidence for the precision of the structures. From an examination of the structure~Fig. 5A! and the PROCHECK analysis~Laskowski et al., 1993 , 1996 ! of the data, the general features of the structure are seen to be essentially identical to the overall structural features found in the solution structure of DHFR{methotrexate~Gargaro et al., 1998! and in the crystal structures of DHFR{methotrexate. NADPH complex~Bolin et al., 1982!.
Backbone dynamics of the DHFR{trimetrexate complex
The overall rotational correlation time t c for the complex of DHFR with trimetrexate was calculated from the 15 N T 1 and T 2 data using procedures developed by Kay et al.~1989!. T 1 and T 2 values were obtained from a total of 128 residues. Local values of the overall correlation time were calculated from the T 1 0T 2 ratios of 54 of the residues~see Materials and methods!; the average of these values gives an overall correlation time of 8.75 6 0.1 ns at 308 K.
The experimental values of the relaxation parameters were interpreted using the model-free formalism~Lipari & Szabo, 1982!, with extensions to include slower internal motions~Clore et al., 1990b! and chemical exchange contributions R ex to the transverse relaxation~Clore et al., 1990a!~see Electronic supplementary material!.
Values of the model-free parameters S 2 , t e , and R ex have been obtained for all 128 residues for which experimental relaxation data were obtained. Figure 6 shows the measured values of the relaxation parameters R 1 , R 2 , and NOE~R i ϭ T i Ϫ1 ! and the calculated generalized order parameters, S 2 , plotted against the corresponding residue number. The t e and R ex values are given in Electronic supplementary material.
Ring flipping in bound trimetrexate
Ring flipping of the 39,49,59-trimethoxyphenyl ring of bound trimetrexate has been studied using 2D ROESY and 1D NMR-1 H spectra of the complex recorded over the temperature range 278 to 313 K. In the 2D ROESY~and 2D NOESY! spectra, one can observe strong exchange cross peaks between H29 and H69 and between CH 3 -39 and CH 3 -59~Fig. 3!. Decreasing the temperature reduces the intensities of these cross peaks and at the same time sharpens the signals. This is typical for slow exchange behavior where separate signals are detected for the exchanging sites and the line widths of the signals have contributions from the exchange process. This dynamic process has been investigated by line shape analysis of the H69 signal in the 1D spectrum of the DHFR{trimetrexate complex. This signal is observed as a wellresolved signal in a noncrowded region of the 1 H spectrum~Fig. 7! and this facilitates measurement of its lineshape. An approximate estimate of the nonexchange contribution to the linewidth was obtained from the mean values of the linewidths of several histi- 
Structure and dynamics in solution of the complex of L. casei
dine HE and Hd signals. The rates of ring flipping obtained from a lineshape analysis ranged from 6 s Ϫ1 at 278 K to 90 s Ϫ1 at 313 K. These values were used to obtain values of enthalpy and entropy of activation~DH ‡ ϭ 62 6 2 kJ mol Ϫ1 and DS ‡ ϭ Ϫ5 6 10 J mol Ϫ1 K Ϫ1 , respectively!.
Discussion
The solution structure of the DHFR{trimetrexate complex
Some indication of the precision of the determined structures is provided by Figure 5 , which shows the superposition of the final family of 22 structures, and by the plot of the RMSD values against the residue numbers shown in Figure 8 . The precision of the structures compares very favorably with that of the structures reported earlier for the DHFR{methotrexate complex~Gargaro et al., 1998!. The latter determination was based on NMR studies of 13 C0 15 N labeled methotrexate and protein samples. The structure determination for the trimetrexate complex was carried out using unlabeled trimetrexate and only 15 N-labeled protein. Notwithstanding this, the number of ligand-protein NOEs assigned for the trimetrexate complex~67! was greater than the number obtained for the methotrexate complex~54!. The methyl substituted quinazoline ring of the bound trimetrexate has more protons than the corresponding pteridine ring of methotrexate and these protons provide increased opportunities for measuring protein-ligand NOEs. Additionally, the favorable dynamic behavior of the trimethoxy ring of trimetrexate allows the measurement of unambiguous NOEs from protons on each side of the ring at low temperature~278 K!. At this temperature the ring flipping is sufficiently slow to allow the H29, H69 and CH 3 -39,CH 3 -59 protons to give separate signals in slow exchange and to allow detection of protein-ligand NOEs in the NOESY spectra. These NOEs can be assigned to protein-ligand NOEs by noting their disappearance on raising the temperature where the increased rate of ring flipping broadens the ligand signals. In contrast, the flipping rates of the p-aminobenzoyl ring of methotrexate causes line broadening of its aromatic proton signals such that no signals could be detected at any of the temperatures studied. The low temperature spectra of the DHFR{trimetrexate complex also allowed us to make specific NOE assignments for the separate protons in the trimetrexate NH 2 groups. A further improvement in the structure determination of the trimetrexate complex resulted from the use of many more NOEs involving stereospecifically assigned protons and more hydrogen bonds than were used in the methotrexate structure calculations. Although 18% fewer intramolecular NOEs were used in the calculations for the trimetrexate complex~resulting from the absence of some Hbs0 Hbs, Hgs0Hbs assignments, which could only be obtained from 13 C data!, the compensating factors mentioned above result in the determined structures of the two complexes being of similar precision. The availability of the spectral and structural data for the methotrexate complex assisted in the structural determination of the trimetrexate complex. High precision structures for proteins of this size can thus be obtained without using 13 C-labeled protein if one has a reference structure to assist in obtaining the initial set of NOE values~see Material and methods!. Figure 9C shows the structures of the three bound inhibitors Although the 2,4-diaminopyrimidine-containing rings occupy essentially the same binding site, the planes of the rings appear to be tilted by 208 with respect to each other~with the trimetrexate structure being in the middle!. The trimethoxy benzene ring of bound trimetrexate is perpendicular to that of trimethoprim. The binding site residues in complexes of dihydrofolate reductase with methotrexate and trimethoprim have been well described in the literature~Bolin et al., 1982; Matthews et al., 1985a; Martorell et al., 1994; Gargaro et al., 1998 !. In each case, the 2,4-diaminopyrimidine ring moiety binds in a very negatively charged pocket involving the side-chain carboxylate group of D26, the hydroxyl group of T116, and the backbone carbonyl groups of L4 and A97. In the methotrexate complex, there are additional electrostatic interactions involving the carboxylate groups of the methotrexate glutamate side chain with H28 and R57. The "middle" part of the methotrexate molecule binds in a pocket containing several hydrophobic amino acids~Fig. 9A! and many of the same residues are involved in binding the trimethoxy ring of trimetho- Gargaro et al., 1998 !. These comparisons need to be made with caution because not all parts of the structure are equally well defined. However, Figure 8A shows that the regions of the protein with the smallest and largest RMSD values for the DHFR{trimetrexate complex are very similar to those previously reported for the DHFR{methotrexate structurẽ see Fig. 5 of Gargaro et al., 1998 !.
Comparisons with structures of related DHFR complexes
Comparison of DHFR{trimetrexate and DHFR{methotrexate structures
The global structure of the DHFR{trimetrexate complex~see Figs. 5, 8, 9 ! is found to be very similar to that of the DHFR{methotrexate complex with the small differences between the structures being localized mainly to regions around the binding site. This is seen from examination of the RMSD values resulting from the pairwise global fitting of the backbone atoms~C, Ca, and N! of the two families of structures for the DHFR complexes with trimetrexate and methotrexate~Fig. 8!. The residues with the largest backbone displacements are in the regions 6-10, 25-31, 72-73, 114-117, and 124-155. The 6-10, 25-31, and 114-117 regions can obviously be implicated in differences between the ligand binding sites as can the 150-155 region, which is on the adjacent b-strand to the 6-10 and 114-117 regions. Differences in the 72-73 region may reflect some uncertainties in the determination of the structure of the loop containing these residues.
The 2,4-diaminopyrimidine ring of each inhibitor binds similarly to the enzyme. In each case the protonated N1 binds to the side-chain carboxylate group of D26~Fig. 5B! and the 2-and 4-amino substituents are positioned to make interactions with T116, L4, and A97 as described earlier~Bolin et al. diaminopyrimidine moiety in each complex are in essentially the same positions in the two complexes indicating that this part of the molecule is binding in the same binding site. Figure 9A shows some of the important hydrophobic side chains, which can be involved in van der Waals interaction with the inhibitors. For the trimetrexate complex, these residues are L19, L27, F30, F49, P50, L54, and A97 while for the methotrexate complex the side chains of the same residues, except for A97~not shown in the figure!, can be involved in the binding. The positions of the side chains of the interacting hydrophobic residues have not changed substantially between the two different complexes. This can be seen by examining Figure 9A and is supported by the observed small values for the RMSD quotients~Fig. 8C! and the fact that all the residues have very similar measured x 1 and x 2 values in both complexes~see Table 3 !. Some small differences were seen for L27, F49, and L54 with the largest difference being seen for the L27 x 1 value~178!. Thus, the drugs are adapting their bound conformations to interact with the same hydrophobic amino acid side chains, which bind in general with relatively unchanged x 1 0x 2 conformations. The small changes in the positions of the interacting side chains in the two complexes~Fig. 9A! must be achieved by the sum of many small relative differences in the backbones of the two complexes.
Comparison of DHFR{trimetrexate and DHFR{trimethoprim complexes
Although the structures determined for the DHFR{trimethoprim complex~Martorell et al., 1994! are of lower precision than those of the trimetrexate complex useful structural comparisons are still possible.
The structures of the binding sites in the two complexes are shown in Figure 9B . The trimetrexate hydrophobic binding pocket is seen to contain L19, L27, F30, F49, P50, L54, and A97 and that for trimethoprim contains the same residues except for A97. In the trimetrexate complex, the hydrophobic residues L19 and F30 interact with the quinazoline B ring whereas in the trimethoprim complex, where this ring is missing, these residues can interact with the trimethoxy ring. Although the rings are in different positions in the binding sites of the two complexes, in each case, the side chains of L27 and F49 are sufficiently close to interact with the trimethoxy ring and substituents. The side chains of residues P50 and L54 also could provide some additional interactions in the trimetrexate complex but these will be smaller in the trimethoprim complex. A97 is correctly positioned to interact with the C5 methyl of bound trimetrexate, which has no equivalent in trimethoprim.
As was found in the earlier comparison of the structures of the trimetrexate and methotrexate complexes, the positions and conformations of the interacting hydrophobic side chains in the protein are not very different. Thus, once again, effective proteinligand interactions are formed by the drug adopting a bound conformation which takes advantage of the existing conformations of the interacting side chains of the protein.
Relaxation parameters
The measured values of the 15 N relaxation parameters~T 1 , T 2 , and NOE! and the calculated generalized order parameter~S 2 ! plotted against the corresponding residue number are shown in Figure 6 . The protein in the DHFR{trimetrexate complex appears to have no really flexible parts: the only residue showing high flexibility is the C-terminal A162. Thus, the data indicate that DHFR{trimetrexate complex is globular~average t c value of 8.75 6 0.1 ns!, which is in good agreement with the determined structure. The mean value obtained for S 2 is 0.86 and the standard deviation is 0.05. There are several residues with S 2 values below the mean value minus one standard deviation, namely, residues 68-71, 102, 110, 122, 131, 133, 145, 146, 155, 161, and 162 . Most of these are near to the unoccupied binding site of the coenzyme or are situated in loop regions.
Ring flipping in bound trimetrexate
The nonlinear fitting of the experimental kinetic data for the trimetrexate ring flipping provides the values: DH ‡ ϭ 62.0 6 2.0 kJ mol Ϫ1 and DS ‡ ϭ Ϫ5 6 10 J mol Ϫ1 K Ϫ1 . Interestingly, the value of DS ‡ is rather close to the values obtained for ring flipping in 39,59-difluoromethotrexate bound to L. casei DHFR~Ϫ15 J mol Ϫ1 K Ϫ1 for binary and Ϫ29 J mol Ϫ1 K Ϫ1 for the ternary complex with NADPH!~Clore et al., 1984!. However, the enthalpy value for ring flipping of trimetrexate is much higher than the values found for 39,59-difluoromethotrexate~DH ‡ ϭ 48.1 kJ mol Ϫ1 for the binary and 41.4 kJ mol Ϫ1 for the ternary complex!. There are two components in the value of DH ‡ : the intrinsic barrier to rotation about the N10-C19 bond and an additional barrier due to interactions of the benzoyl ring with protein residues including any conformational rearrangements required to relieve steric interactions hindering the ring flipping. For trimetrexate, the intrinsic barrier to rotation would be expected to be less than that for methotrexate, where the intrinsic barrier includes the effects of hindered rotation about the amide bond to the glutamate moiety. Therefore, a substantial contribution to the value of DH ‡~6 2 kJ mol Ϫ1 ! in the trimetrexate complex arises from the additional barrier. Because the structures of the ligand binding sites are fairly similar in the complexes formed with each of the drugs, the difference in the DH ‡ values for complexes of DHFR with trimetrexate and with 39,59-diflouromethotrexate probably reflects additional hydrophobic interactions of the 39,49,59-trimethoxyphenyl ring of trimetrexate with residues in the active site. These interactions would need to be broken before ring flipping can take place, thus contributing to the activation barrier~estimated contribution of 10 to 15 kJ mol Ϫ1 , that is, the difference 62 Ϫ 48 kJ mol Ϫ1 !.
Materials and methods
Sample preparation
L. casei dihydrofolate reductase was prepared as described previously from an Escherichia coli strain in which the structural gene for the L. casei enzyme had been cloned~Dann et al., 1976; Andrews et al., 1985!. Trimetrexate was a gift from Warner-Lambert0 Parke-Davis~Pontypool, Gwent!. Just over one equivalent of trimetrexate was added as a solid to the solution of dihydrofolate reductase: after 3-10 h standing, undissolved trimetrexate was separated by centrifugation and the final solution dialyzed to remove uncomplexed trimetrexate.
Binding data
Methotrexate and trimetrexate bind very tightly to DHFR, which makes direct measurement of the binding constant difficult. However, the ratios of the binding constants K a MTX 0K a TMQ and K a TMQ 0K a TMP can be estimated from competition experiments. A sample containing a 1:1:1 mixture of DHFR, MTX, and TMQ was made at pH 6.5 in 500 mM KCl and 50 mM potassium phosphate and examined after 2 and 7 days to confirm that complete equilibrium had been reached. At equilibrium, the ratio K a MTX 0K a TMQ equals $@DHFR{MTX#0@DHFR{TMQ#%{$@TMQ#0@MTX#%. Defining h as the ratio @DHFR{MTX#0@DHFR{TMQ#, and assuming that @DHFR free # ; 0, which is a good assumption for tightlybinding ligands, it can be shown that for 1:1:1 mixture of DHFR, MTX, and TMQ, ratio @TMQ#0@MTX# can be approximated to h, and therefore K a MTX 0K a TMQ ϭ h 2 . The ratio h was obtained from the integrated areas of well-resolved complex-specific signals in the 1D 1 H spectra of the complexes. The ratio of binding constants K a MTX 0K a TMQ is 20 6 10. A similar experiment carried out on a sample containing a 1:1:1 mixture of DHFR, TMP, and TMQ gave the ratio of binding constants, K a TMQ 0K a TMP ϭ 10 6 5. K a TMQ can then be estimated as ;2 ϫ 10 8 M Ϫ1 using the previously reported values for K a MTX~2 ϫ 10 9 M Ϫ1 ! and K a TMP~2 ϫ 10 7 M Ϫ1 ! Birdsall et al., 1980!.
NMR experiments
The NMR experiments were carried out on Varian UNITY and UNITY plus spectrometers operating at proton frequencies of 600 and 500 MHz, respectively. The spectra were recorded at 278, 288, or 308 K on either unlabeled or 15 N-labeled protein samples with volumes of 0.6 mL and at concentrations 1 or 4 mM in 500 mM potassium chloride and 50 mM potassium phosphate buffer, pH* 6.5, made up either in D 2 O or in 90% H 2 O010% D 2 O~pH* values are pH meter readings uncorrected for deuterium isotope effects!.
Full details of the NMR experiments are provided in Electronic supplementary material. 2D DQF-COSY, TOCSY, NOESY, and ROESY spectra were recorded at temperatures between 278 and 308 K for both H 2 O and D 2 O samples of DHFR{trimetrexate. 2D and 3D experiments using uniformly 15 N labeled protein, HSQC, TOCSY-HMQC, NOESY-HMQC, ROESY-HMQC, and HNHB were also carried out. Longitudinal and transverse 15 N relaxation times~T 1 and T 2 ! and 15 N$ 1 H%NOE values were measured at 308 K using the pulse sequences described by Kay and co-workers~1992!. The 1 H chemical shifts were measured from dioxane as an internal reference and then referenced to sodium 2,2-dimethyl-2-silapentane-5-sulfonate~DSS!, relative to which the chemical shift of dioxane is 3.75 ppm. The 15 N chemical shifts were referenced indirectly to liquid NH 3 using the g ratios method~Live et Wishart et al., 1996 !.
Structure and dynamics in solution of the complex of L. casei NMR determined constraints
Distance constraints
Interproton distance constraints were obtained from NOEs measured in 2D and 3D NOESY and ROESY spectra recorded in D 2 O and H 2 O. The set of distance constraints used for generation of initial structures contained unambiguously assigned NOEs, and also a limited set of NOEs for which the ambiguity was resolved using the NMR structures of the DHFR{MTX complex~Gargaro et al., 1998!. The total number of NOEs used for initial structure generation was about 900. When the initial structures were being generated, assignments of additional NOEs were carried out in the usual iterative manner. Cross-peak intensities were classified as strong~0.0-2.5 Å!, medium~0.0-3.5 Å!, weak~0.0-4.5 Å!, and very weak~0.0-5.5 Å!. Pseudoatom center averaging was applied for methyl groups and all distance constraints based on NOEs involving methyl groups had their upper limits increased by 1 Å. An r Ϫ6 sum averaging, where the r Ϫ6 distance was weighted by the number of ambiguous NOEs~Nilges, 1995!, was applied for all nonstereospecifically assigned pairs of methyl groups, all nonstereospecifically assigned protons in methylene groups and for the Hd and HE protons in phenylalanine and tyrosine rings.
The number and distribution of NOEs used in the structural calculations are given in Table 1~and 
Torsion angle constraints and stereospecific assignments
The program AngleSearch~Polshakov et al., 1995b! was used to determine the f, c, x 1 , and x 2 torsional angle constraints and the stereospecific assignments for all the b-methylene protons and for valine g-methyl groups as described previously for the DHFR{methotrexate complex~Gargaro et al., 1998!. The error limits obtained from AngleSearch for the dihedral angles were increased to 6308 for f, 6408 for c, and 6308 and 6408 for x 1 and x 2 , respectively, to take into account local mobilities and the uncertainties in the Karplus equations used in these studies.
The ranges for the trimetrexate torsion angles t 1~C 5-C6-C9-N10! and t 2~C 6-C9-N10-C19! were determined from the AngleSearch analysis of ROESY effects between protons of the drug. The final restraint list contained 345 dihedral angles~f, 123; c, 120; x 1 , 96; x 2 , 4; trimetrexate, 2!.
Hydrogen bond constraints
Hydrogen bond constraints involving backbone NH protons were included in the calculation only at the last stage of structure refinement after they had been identified in the family of structures obtained without their use. Donors of hydrogen bonds corresponding to slowly exchanging NH protons were identified from analysis of the rates of H r D exchange for backbone amide protons~measured at 288 K from a series of HSQC spectra of DHFR{trimetrexate complexes recorded between 5 and 880 min after dissolving the sample in D 2 O as described in Electronic supplementary material!. Acceptors of hydrogen bonds were selected if there were only one possible oxygen atom within 3 Å distance of the corresponding amide proton in the family of structures and each hydrogen bond was described with two restraints. The final calculations included 142 hydrogen bond restraints involving backbone NH protons~corresponding to 71 hydrogen bonds!.
A hydrogen bond restraint corresponding to the T34 g-hydroxyl proton interacting with the carbonyl oxygen of F30 was included in the structure calculation. A signal for the T34 g-hydroxyl proton was observed in all NMR spectra recorded in H 2 O and was also observed for the DHFR{methotrexate complex~Gargaro et al., 1998!. To specify the geometry of the interactions of the trimetrexate HN1 and HN21 protons with the D26 b-carboxylate oxygens Polshakov et al., 1995a!, two distance restraints and four additional torsion angles were included in the final stage of structure calculation to maintain the planarity of the 2-NH 2 group and the pyrimidine ring.
The final constraint list contained a total of 144 hydrogen bond constraints.
Structure calculations
The structure calculations were performed in an iterative fashion using X-PLOR 3.1~Brünger, 1992!. Initially, a set of 100 structures was generated using a combined distance geometry0simulated annealing approach~Nilges et al., 1988, 1991!. The distance geometry used subembedding based on the Ca, Ha, N, HN, O, C, and Cb atoms. The ligand was included from the beginning of the calculations. Structures produced by this method were then regularized using simulated annealing consisting of 6 ps of dynamics at 2,000 K with the force constants determining covalent geometry scaled during this stage to their final values, followed by cooling to 100 K with the vdW repulsive term increased from 0.003 to 0.4 and the vdW radii decreased from 0.9 to 0.8 of their standard values and then subjected to 1,000 steps of conjugate gradient minimization. Fifty-four of the structures with essentially the correct fold as judged by comparison with NMR structures of the DHFR{methotrexate complex~Gargaro et al., 1998! were accepted for further refinement. These structures were used to resolve ambiguities in the NOE data set and then subjected to a slow cooling simulated annealing refinement~from 1000 to 100 K during a 20 ps period!. This stage of the process was repeated several times including progressively more NOE and dihedral angle constraints. Twenty-four structures with no NOE violations greater than 0.2 Å and no dihedral angle violations greater than 58 were accepted for the final refinement. At this stage, the hydrogen bonds and the constraints modeling specific interactions between 2,4-diaminopyrimidyl moiety of trimetrexate and the carboxy group of D26 were introduced. The final refinement protocol was essentially the same as the previous one followed by 1,000 steps of conjugate gradient minimization and yielded 22 structures with no distance violation greater then 0.1 Å and no dihedral angle violations greater than 38. Calculations of the final family of 22 structures~shown in Fig. 5 ! were carried out with double the earlier cooling MD period~40 ps!. Figure 8A shows the RMSD values calculated for the backbone atoms~Ca, C, N! using pairwise global fitting of these 22 structures. Bond lengths were constrained using SHAKE~Ryckaert et al., 1977!. Parameter and topology files for trimetrexate were constructed using coordinates from the crystal structure of trimetrexate~Hempel & Camerman, 1988!.
Calculations were performed on Silicon Graphics~Power Indigo2! and Sun~Sparc 10! computers. Coordinates for the 22 refined structures have been deposited in the Brookhaven Protein Data Bank~coordinates ID code1bzf; assignments and restraints ID code r1bzfmr!.
Analysis of calculated structures
Structures were visualized using INSIGHT II~Molecular Simulations Inc., Burlington, Massachusetts! and GRASP~Nicholls et al., 1991 ! and analyzed using X-PLOR 3.1~Brünger, 1992 ! and PROCHECK-NMR0AQUA~Laskowski et al., 1993 , 1996 !. The analysis showed that there are no residues in the disallowed regions of the Ramachandran plot~Fig. 3 in Electronic supplementary material!. A representative structure S rep was selected from the ensemble of calculated structures as being the one that is closest to all the other structures and thus gives the lowest sum of pairwise RMSD for the remainder of the structures in the family. , and the values of r i will be closer to 1. However, residues that have well-defined side chains within families but that have large differences between two complexes will have large values of r i~s ee Fig. 8 !. In Figure 8C , only a-helix B~between residues 26 and 28! shows a significant local displacement between the two DHFR complexes probably due to the interaction between H28 and the glutamate moiety of methotrexate, which is absent in the trimetrexate complex.
T 1 , T 2 and 15 N{ 1 H} NOE data analysis
The relaxation data were analyzed using the "model-free" approach of Lipari and Szabo~1982! with the assumption of isotropic tumbling. The spectra used in the T 1 , T 2 , and 15 N$ 1 H% NOE experiments were processed and analyzed with the FELIX program Molecular Simulations Inc.!. The time domain data were zerofilled to 1K and 2K complex points in the t 1 and t 2 dimensions, and a Gaussian window function was applied in both dimensions before transformation. The T 1 and T 2 values~giving the rates R 1 and R 2 , respectively! and their standard deviations were obtained from nonlinear fits of both integral peak volumes and the peak intensities. Standard deviations of 15 N$ 1 H% NOE values were calculated using the RMS noise of background regions~Farrow et al., 1994!. For most of the residues, the results were identical, but for the residues with signals situated in more crowded regions the results obtained from peak intensities~rather than from volumes! had smaller standard deviations, and therefore only these were used for further analysis~results shown in Fig. 6 !. T 1 and T 2 values were obtained from a total of 128 residues.
The overall correlation time t c for the complex of DHFR with trimetrexate was calculated from the T 1 0T 2 ratios~Kay et al., 1989!. An initial selection was made of residues that had T 1 and T 2 values within one standard deviation from the mean values over all residues~93 of 128 residues!. Of these, the 54 residues that had T 1 0T 2 ratios within one standard deviation of the mean of the subset of 93 were then selected for further analysis. The calculations yield an average t c value of 8.75 6 0.1 ns. The overall correlation time was treated as a fixed parameter in the analysis of the relaxation data in terms of the model-free formalism.
Calculation of the model-free parameters from the measured relaxation rate constants and the NOE enhancements was performed by Powell minimization~Press et al., 1992! of a global target function x 2 summed over all residues using software written in-house~see Electronic supplementary material!. In this analysis, 15 N-1 H dipolar relaxation and 15 N CSA relaxation were examined using equations in the literature~Kay et al., 1989; Farrow et al., 1994 !. Values of 1.02 Å and 160 ppm were assumed for the N-H bond-length and 15 N CSA, respectively. For some residues, an exchange term R ex was included to represent line broadening due to exchange processes on a timescale much slower than the overall rotational correlation time.
The relaxation data were fitted to three functional forms of the model free spectral density functions given in the literature~Lipari & Szabo, 1982; Clore et al., 1990a Clore et al., , 1990b ! and described in Electronic supplementary material. Kinemage 2. Comparison of three representative structures of binary complexes of DHFR-with trimetrexate, methotrexate, and trimethoprim.
Supplementary material in Electronic Appendix
